3rd rare cancer case reported connected to Allergan's breast implants
Lee Seung-joon, second from left, a lawyer from the Tae Il Law Firm, who is leading a lawsuit against Allergan seeking damages for plaintiffs affected by its breast implants, arrives at the Seoul Central District Prosecutors' Office in this Sept. 23, 2019 photo. Courtesy of Lee Seung-joonBy Bahk Eun-jiA third patient has been diagnosed with a rare form of cancer caused by Allergan's Biocell textured breast implants, a local law firm leading a lawsuit against the U.S. company said Monday.Lee Seung-joon, a lawyer at Tae Il Law Firm, which has been gathering people to participate in the lawsuit since last year and filed the suit against Allergan, which was acquired by AbbVie in May, for damages, said he was distributing the press release about the third patient as the Ministry of Food and Drug Safety (MFDS) had not officially announced the third incideence. “So far, three patients have so far been reported in the past few months since the company announced a compensation plan in September last year, which only reflects the high risk of the possibility of additional cases,” L
